KEY vs ZYME
KeyCorp (KEY) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the KEY and ZYME stock pages for the full models.
Not investment advice.